Section Editor: David Driman MBChB FRCPC
November 13, 2026
Gastric dysplasia is a precancerous change in the cells that line the stomach. It is not cancer, but it means the cells have started to look and grow abnormally, and over time they can develop into stomach cancer. Dysplasia is graded as low-grade or high-grade, and finding it gives your doctors a chance to remove the abnormal cells or monitor them closely before cancer develops.
Gastric dysplasia is usually not the main diagnosis in a pathology report. Instead, it is described as part of a report for another condition, such as a biopsy for gastritis, a polyp, or a tumor. This article explains where gastric dysplasia appears in a pathology report, what the grade and type mean, and what usually happens next.
Gastric dysplasia can appear in several kinds of pathology reports. The meaning of the finding depends partly on where it was found, so it helps to know which kind of report you have.
Some reports use the term intraepithelial neoplasia instead of dysplasia. The two terms mean the same thing.
Gastric dysplasia usually develops after many years of damage to the stomach lining. The most common cause is a long-lasting infection with the bacterium Helicobacter pylori. The infection causes long-term inflammation, which can lead step by step to atrophic gastritis, intestinal metaplasia, dysplasia, and finally cancer. Not everyone moves through every step, and most people with gastritis never develop dysplasia.
Other factors that increase the risk of these changes include smoking, heavy alcohol use, a diet high in salt, and autoimmune atrophic gastritis. Rarely, gastric dysplasia develops in people with an inherited condition, such as familial adenomatous polyposis, which causes many polyps in the stomach and bowel.
Gastric dysplasia does not usually cause symptoms on its own. It is most often found during an endoscopy done for another reason, such as indigestion, anemia, or follow-up of atrophic gastritis or intestinal metaplasia. Symptoms are usually caused by the underlying gastritis rather than the dysplasia itself.
A pathologist identifies gastric dysplasia by examining a biopsy or removed tissue from the stomach under a microscope. Endoscopy alone cannot diagnose dysplasia, although the endoscopist may see a raised, flat, or discolored area that looks suspicious.
Under the microscope, the pathologist examines the glandular cells lining the stomach. In dysplasia, these cells have larger, darker nuclei than normal, are crowded together, and do not mature normally as they move toward the surface. The abnormal cells stay within the lining and do not grow into the tissue below it, which separates dysplasia from cancer.
Gastric dysplasia can be difficult to diagnose. For this reason, the 2025 American Gastroenterological Association (AGA) clinical practice update recommends confirming all dysplasia with an experienced gastrointestinal pathologist. You may send your biopsy for a second opinion before treatment is planned.
The grade of gastric dysplasia describes how abnormal the cells look under the microscope. The World Health Organization (WHO) classification (5th edition, 2019) uses a two-tier system of low grade and high grade. The grade is the most important part of the finding, because it guides how quickly your doctors will act.
Indefinite for dysplasia means the pathologist saw changes in the stomach lining but could not tell whether they were dysplasia or a reaction to injury. This often happens with active inflammation, an ulcer, or a small or damaged sample. Inflamed and healing cells can look abnormal in the same way that dysplastic cells do. Your doctor will usually treat any H. pylori infection or inflammation and then repeat the endoscopy with new biopsies.
Pathologists divide gastric dysplasia into types based on which normal cells the abnormal cells look like. Your report may name the type, especially when the dysplasia forms an adenoma.
Both types are precancerous, and grade matters more than type when planning treatment.
The risk that gastric dysplasia will turn into cancer depends mostly on the grade. In studies that followed people over time, about 1 in 100 people with low-grade dysplasia developed stomach cancer each year. The risk was much higher for high-grade dysplasia, ranging from about 6 to 19 in 100 people each year. These numbers come from people who were watched rather than treated, so removing the dysplasia lowers the risk.
The risk is also higher when the dysplasia forms a visible growth or when intestinal metaplasia is widespread in the stomach.
What happens after gastric dysplasia is found depends on the grade and on whether your doctor can see the abnormal area during endoscopy. The following approach is based on the European MAPS II guideline (2019) and recent AGA clinical practice updates.
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name